Immunomodulatory Effects of Nintedanib on Human Blood Monocytes/Macrophages from Patients with Idiopathic Pulmonary Fibrosis
Biomolecules · 18.02.2026 · 16 (2) · 319
DOI: 10.3390/biom16020319 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, online erschienen am 18.02.2026. Verfasst von Maria Talmon und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, University of Piemonte Orientale, Via Bovio 6, 28100 Novara, Italy. Hauptthemen laut MEDLINE: Idiopathic Pulmonary Fibrosis, Indoles, Monocytes, Macrophages. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Boehringer Ingelheim (Italy), Boehringer Ingelheim Italia S.p.A..
Abstract (Originalsprache)
Background
Nintedanib (NTD) is an inhibitor of several tyrosine kinases whose role in the pathogenesis of idiopathic pulmonary fibrosis (IPF) is well recognized. Therefore, NTD was approved for the management of IPF about ten years ago. NTD has been demonstrated to have immunomodulatory effects in vitro. We now evaluated the effects of NTD on monocyte/macrophage phenotype isolated from IPF patients treated with NTD.
Methods
Monocytes were isolated from IPF patients naïve for treatments and used as such or differentiated into M1- and M2-like macrophages. The cellular phenotype (characterized by the expression pro- and anti-fibrotic surface markers) and responsiveness (characterized by oxidative stress and cytokine expression/release) were evaluated, at T0 (before treatment starts) and after 6 months of treatment with a 150 mg capsule of NTD twice a day (T1).
Results
Following differentiation, both M1 and M2 macrophage populations, derived from monocytes isolated from patients treated with NTD, present a higher percentage of cells positive for anti-fibrotic CD80/CD86 and expressing less profibrotic CD206/CD163. Importantly, gene expression and release of the pro-fibrotic factor TGF-β were significantly decreased at T1.
Conclusions
These results show that although it does not have a direct effect on monocyte phenotype/responsiveness, NTD in vivo appears to prime monocytes to differentiate preferentially towards an anti-fibrotic macrophage phenotype, suggesting that it has an immunomodulatory effect on macrophage polarization. This data leads us to hypothesize that NTD could also induce this change in vivo, thus contributing to the improvement of the patient’s fibrotic state.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences, University of Piemonte Orientale, Via Bovio 6, 28100 Novara, Italy.
- Department of Health Sciences, School of Medicine, University of Piemonte Orientale, Via Solaroli, 17, 28100 Novara, Italy.
- Division of Respiratory Diseases, Maggiore della Carità University Hospital, C.so Mazzini 18, 28100 Novara, Italy.
ORCID-Profile: Hari Baskar Balasubramanian, Chiara Mocchetti, Lara Camillo, Luigia Grazia Fresu
Förderung
- Boehringer Ingelheim (Italy)
- Boehringer Ingelheim Italia S.p.A.
Zitieren
APA
Talmon, M., Mares, A., Balasubramanian, H. B., Mocchetti, C., Camillo, L., Balbo, P., Fresu, L. G., & Patrucco, F. (2026). Immunomodulatory Effects of Nintedanib on Human Blood Monocytes/Macrophages from Patients with Idiopathic Pulmonary Fibrosis. Biomolecules, 16(2), 319. https://doi.org/10.3390/biom16020319
Vancouver
Talmon M, Mares A, Balasubramanian HB, Mocchetti C, Camillo L, Balbo P, et al. Immunomodulatory Effects of Nintedanib on Human Blood Monocytes/Macrophages from Patients with Idiopathic Pulmonary Fibrosis. Biomolecules. 2026;16(2):319. doi:10.3390/biom16020319
BibTeX
@article{Talmon2026,
author = {Talmon, Maria and Mares, Arianna and Balasubramanian, Hari Baskar and Mocchetti, Chiara and Camillo, Lara and Balbo, Piero and Fresu, Luigia Grazia and Patrucco, Filippo},
title = {Immunomodulatory Effects of Nintedanib on Human Blood Monocytes/Macrophages from Patients with Idiopathic Pulmonary Fibrosis},
journal = {Biomolecules},
year = {2026},
volume = {16},
number = {2},
pages = {319},
doi = {10.3390/biom16020319}
}
EUVIMED